Market Overview:
The global metildigoxin market is expected to grow at a CAGR of 3.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as an increase in the prevalence of heart failure, rising geriatric population, and technological advancements in cardiac devices. However, the high cost of treatment and lack of awareness about heart failure are some factors that are restraining the growth of this market. The global metildigoxin market is segmented on the basis of type, application, and region. On the basis of type, it is divided into tablet and other forms (injection/infusion). The tablet form dominates this market owing to its ease-of-use and patient compliance issues associated with other forms such as injections/infusions. By application, it is classified into cardiac applications (heart failure) and other applications (renal dialysis patients). The cardiac applications segment accounts for a majority share in this market due to increasing incidence rates for heart failures across all regions globally. Geographically, it is analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U K Rest Of Europe), Asia Pacific excluding Japan) [China India Australia & New Zealand ASEAN Rest Of APAC], Japan], Middle East & Africa ([GCC Countries Israel South Africa Rest Of MEA]).
Product Definition:
Metildigoxin is a digitalis glycoside used to treat congestive heart failure and atrial fibrillation. It increases the force of contraction of the heart muscle and slows conduction through the AV node.
Tablet:
Tablet is a portable device that can be used to consume drugs. It’s major application is in the pharmaceutical industry, where it plays an important role in drug delivery. Tablets are also used by patients who have difficulty swallowing large pills and by kids as a medicine dosage form. The increasing prevalence of chronic diseases such as cancer, diabetes and arthritis has led to an increase in demand for tablets globally which will boost market growth over the forecast period.
Other:
Other is a chemical compound that includes natural and synthetic compounds. Other majorly includes amino acids, peptides, proteins, nucleotides and small molecules such as alcohols & ketones. Proteins are the largest source of other in the human body; they make up approximately 30% of an individual’s total body weight.
Application Insights:
Cardiac metildigoxin application dominated the global market in 2017, owing to its high usage in cardiac arrest cases. Cardiac arrest is a medical emergency and requires immediate treatment with cardiopulmonary resuscitation (CPR) and other life-saving procedures. In such cases, metildigoxin tablets are used as an antidote to treat the underlying cause of cardiac arrest. The drug also finds applications in treating other conditions such as respiratory depression caused by carbon monoxide or barbiturates poisoning. However, increasing awareness about these drugs has led to reduced consumption for non-cardiac conditions due to availability of alternative treatments with fewer side effects.
Other metildigoxin applications include accidental poisonings.
Regional Analysis:
North America accounted for the largest share of over 40.0% in 2017, owing to the presence of a large number of metildigoxin-based pharmaceuticals and biologics manufacturers coupled with high healthcare expenditure in this region. The U.S., which is one of the most lucrative markets for drugs, has also witnessed an increase in R&D investment by multinational companies as well as government agencies to develop novel formulations that are better than existing products and have a longer duration of action.
Asia Pacific is anticipated to be one of the fastest growing regions due to factors such as increasing geriatric population base prone to cardiac disorders along with rising healthcare expenditure levels especially in China & India.
Growth Factors:
- Increasing prevalence of heart failure: The global prevalence of heart failure is expected to increase from 26 million in 2011 to over 40 million by 2030. This will create a large pool of patients who will require treatment, including those for whom metildigoxin may be an appropriate therapy.
- Growing awareness and use of digoxin-specific antibody fragments (DSAF): DSAF are increasingly being used as an alternative to digoxin, as they offer several advantages such as improved safety and tolerability profile, and reduced risk for drug interactions. As the use of DSAF grows, demand for metildigoxin is also likely to increase.
- Expanding indications for metildigoxin: Metildigoxin is currently approved only for the treatment of congestive heart failure (CHF), but there is increasing evidence that it may also be beneficial in other cardiac conditions such as atrial fibrillation and chronic stable angina pectoris. If these indications are approved by regulatory authorities, this would expand the market potential for metildigoxin significantly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Metildigoxin Market Research Report
By Type
Tablet, Other
By Application
Cardiac, Other
By Companies
Centroflora, Tianjin Kaiwei and Yongli United Chemical, Kemprotec
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Metildigoxin Market Report Segments:
The global Metildigoxin market is segmented on the basis of:
Types
Tablet, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiac, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Centroflora
- Tianjin Kaiwei and Yongli United Chemical
- Kemprotec
Highlights of The Metildigoxin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Other
- By Application:
- Cardiac
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Metildigoxin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Metildigoxin is a natural compound found in the mushroom Metilusium volutans. It has been shown to have anti-inflammatory and analgesic properties.
Some of the major companies in the metildigoxin market are Centroflora, Tianjin Kaiwei and Yongli United Chemical, Kemprotec.
The metildigoxin market is expected to register a CAGR of 3.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Metildigoxin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Metildigoxin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Metildigoxin Market - Supply Chain
4.5. Global Metildigoxin Market Forecast
4.5.1. Metildigoxin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Metildigoxin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Metildigoxin Market Absolute $ Opportunity
5. Global Metildigoxin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Metildigoxin Market Size and Volume Forecast by Type
5.3.1. Tablet
5.3.2. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Metildigoxin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Metildigoxin Market Size and Volume Forecast by Application
6.3.1. Cardiac
6.3.2. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Metildigoxin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Metildigoxin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Metildigoxin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Metildigoxin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Metildigoxin Demand Share Forecast, 2019-2026
9. North America Metildigoxin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Metildigoxin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Metildigoxin Market Size and Volume Forecast by Application
9.4.1. Cardiac
9.4.2. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Metildigoxin Market Size and Volume Forecast by Type
9.7.1. Tablet
9.7.2. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Metildigoxin Demand Share Forecast, 2019-2026
10. Latin America Metildigoxin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Metildigoxin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Metildigoxin Market Size and Volume Forecast by Application
10.4.1. Cardiac
10.4.2. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Metildigoxin Market Size and Volume Forecast by Type
10.7.1. Tablet
10.7.2. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Metildigoxin Demand Share Forecast, 2019-2026
11. Europe Metildigoxin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Metildigoxin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Metildigoxin Market Size and Volume Forecast by Application
11.4.1. Cardiac
11.4.2. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Metildigoxin Market Size and Volume Forecast by Type
11.7.1. Tablet
11.7.2. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3 By Application
11.10.4. By Sales Channel
11.11. Europe Metildigoxin Demand Share, 2019-2026
12. Asia Pacific Metildigoxin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Metildigoxin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Metildigoxin Market Size and Volume Forecast by Application
12.4.1. Cardiac
12.4.2. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Metildigoxin Market Size and Volume Forecast by Type
12.7.1. Tablet
12.7.2. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Metildigoxin Demand Share, 2019-2026
13. Middle East & Africa Metildigoxin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Metildigoxin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Metildigoxin Market Size and Volume Forecast by Application
13.4.1. Cardiac
13.4.2. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Metildigoxin Market Size and Volume Forecast by Type
13.7.1. Tablet
13.7.2. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Metildigoxin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Metildigoxin Market: Market Share Analysis
14.2. Metildigoxin Distributors and Customers
14.3. Metildigoxin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Centroflora
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Tianjin Kaiwei and Yongli United Chemical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Kemprotec
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
